MADISON, Wis., Oct. 28, 2016 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced that Cologuard, the first and only FDA-approved noninvasive, stool DNA-based colorectal cancer screening test, has won the 2016 10th Annual Prix Galien USA Award for best medical technology product. Awarded by the Galien Foundation, the Prix Galien USA awards are among the nation's highest honors recognizing biomedical and technology product achievement associated with improving the human condition.
Revenues exceed $28 million, grow 123 percent year-over-year, 33 percent sequentially
MADISON, Wis., Oct. 26, 2016 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenues of $28.1 million during the third quarter ended Sept. 30, 2016, an increase of 123 percent from $12.6 millionin the third quarter of 2015. The company completed approximately 68,000 Cologuard tests during the quarter, an increase of approximately 100 percent from the same quarter of 2015. Since the launch of Cologuard and through the end of the third quarter of 2016, nearly 50,000 providers have ordered the test.
Cologuard offers opportunity for health plans, systems & providers to improve quality ratings
MADISON, Wis., Oct. 3, 2016 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that Cologuard® is now included in the 2017 Healthcare Effectiveness Data and Information Set (HEDIS) quality measures for colorectal cancer screening. The new quality measures were published by the National Committee for Quality Assurance (NCQA). More than 90 percent of America's health plans measure quality based on HEDIS.
Patients, physicians, health systems and insurers all stand to gain from the inclusion of Cologuard in the HEDIS measures.
Topics: Investor Relations
Annual Business Intelligence Group (BIG) awards recognize industry leadership and performance
MADISON, Wis., Oct. 6, 2016 – Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company received the Business Intelligence Group’s 2016 Company of the Year BIG Award for Business in the Health Care category.